Puma Biotechnology
PBYI
PBYI
174 hedge funds and large institutions have $2.13B invested in Puma Biotechnology in 2018 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 70 increasing their positions, 55 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 178 → 174 (-4)
12% less capital invested
Capital invested by funds: $2.42B → $2.13B (-$295M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
174
Holding in Top 10
1
Calls
$82.1M
Puts
$82M
Top Buyers
| 1 | +$124M | |
| 2 | +$46.9M | |
| 3 | +$28.5M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$28M |
| 5 |
Jennison Associates
New York
|
+$27.5M |
Top Sellers
| 1 | -$74.6M | |
| 2 | -$69.8M | |
| 3 | -$34.5M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$34M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$25.8M |